Wird geladen...
Adjunctive brexpiprazole in patients with major depressive disorder and anxiety symptoms: an exploratory study
BACKGROUND: Major depressive disorder (MDD) with concurrent anxiety symptoms may signal a difficult‐to‐treat patient. Brexpiprazole is a serotonin–dopamine activity modulator: a partial agonist at 5‐HT(1A) and dopamine D(2) receptors at similar potency, and an antagonist at 5‐HT(2A) and noradrenalin...
Gespeichert in:
| Veröffentlicht in: | Brain Behav |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5064333/ https://ncbi.nlm.nih.gov/pubmed/27781135 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.520 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|